Brief: SynAct Pharma Appoints Torbjørn Bjerke As New CEO
April 3 (Reuters) - SynAct Pharma AB SYNACT.ST :
* SYNACT PHARMA APPOINTS TORBJØRN BJERKE AS NEW CEO
* ANNOUNCED APPOINTMENT OF COMPANY'S CURRENT CHAIRMAN
TORBJØRN
BJERKE MD, AS ITS NEW CHIEF EXECUTIVE OFFICER
* NOMINATION COMMITTEE WILL PROPOSE TO ANNUAL GENERAL
MEETING THAT
CURRENT BOARD MEMBER ULI HACKSELL SHOULD BE APPOINTED AS NEW
CHAIRMAN OF BOARD
Source text for Eikon: ID:nMFN2mhCyX
Further company coverage: SYNACT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on SynAct Pharma AB
See all newsSweden's SynAct Pharma Q3 net loss narrows as expenses fall
Brief: SynAct Pharma Q3 Net Income SEK -32.177 Million
Brief: SynAct Pharma Signs First Commercial Partnership For Resomelagon
Brief: WHO Names Resomelagon Among Key Dengue Drug Candidates
Brief: SynAct Pharma Says Advance Analysis Supports Phase 3 Development